APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Micafungin Sodium for Injection

Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.

Selected research

Market Outlook & Growth Opportunities

Global Micafungin Sodium for Injection Market Outlook and Growth Opportunities 2026

Report ID 174013120422 December 2025193 pages

Choose your research edition.

Industry ResearchMicafungin Sodium for Injection Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Micafungin Sodium for Injection Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Micafungin Sodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Micafungin Sodium for Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Micafungin Sodium for Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.

North America is the largest Micafungin Sodium for Injection market with about 28% market share. Europe is follower, accounting for about 26% market share.

The key players are Astellas etc. Astellas occupied about 97% market share.

Read the full market overview

This report provides an overview of the global Micafungin Sodium for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Micafungin Sodium for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Micafungin Sodium for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Micafungin Sodium for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Micafungin Sodium for Injection Segment by Company

Astellas

Micafungin Sodium for Injection Segment by Type

50 mg Single-use Vial

100 mg Single-use Vial

Micafungin Sodium for Injection Segment by Application

Candidemia

Respiratory Mycosis

Gastrointestinal Mycosis

Micafungin Sodium for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Micafungin Sodium for Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Micafungin Sodium for Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Micafungin Sodium for Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Micafungin Sodium for Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Micafungin Sodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Micafungin Sodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Micafungin Sodium for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Micafungin Sodium for Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Micafungin Sodium for Injection industry.

Chapter 3: Detailed analysis of Micafungin Sodium for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Micafungin Sodium for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Micafungin Sodium for Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Micafungin Sodium for Injection Industry Trends Table 2. Micafungin Sodium for Injection Industry Drivers Table 3. Micafungin Sodium for Injection Industry Opportunities and Challenges Table 4. Micafungin Sodium for Injection Industry Restraints Table 5. Global Micafungin Sodium for Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Micafungin Sodium for Injection Revenue Share by Company (2021-2026) Table 7. Global Micafungin Sodium for Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Micafungin Sodium for Injection Sales Volume Share by Company (2021-2026) Table 9. Global Micafungin Sodium for Injection Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Micafungin Sodium for Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Micafungin Sodium for Injection Key Company Manufacturing Base & Headquarters Table 12. Global Micafungin Sodium for Injection Company, Product Type & Application Table 13. Global Micafungin Sodium for Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Micafungin Sodium for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50 mg Single-use Vial Table 18. Significant Companies of 100 mg Single-use Vial Table 19. Global Micafungin Sodium for Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Micafungin Sodium for Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Micafungin Sodium for Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Micafungin Sodium for Injection Sales Volume Share by Type (2021-2026) Table 23. Global Micafungin Sodium for Injection Sales Volume Share by Type (2027-2032) Table 24. Global Micafungin Sodium for Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Micafungin Sodium for Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Micafungin Sodium for Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Micafungin Sodium for Injection Sales Value Share by Type (2021-2026) Table 28. Global Micafungin Sodium for Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Candidemia Table 30. Significant Companies of Respiratory Mycosis Table 31. Significant Companies of Gastrointestinal Mycosis Table 32. Global Micafungin Sodium for Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Micafungin Sodium for Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Micafungin Sodium for Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Micafungin Sodium for Injection Sales Volume Share by Application (2021-2026) Table 36. Global Micafungin Sodium for Injection Sales Volume Share by Application (2027-2032) Table 37. Global Micafungin Sodium for Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Micafungin Sodium for Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Micafungin Sodium for Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Micafungin Sodium for Injection Sales Value Share by Application (2021-2026) Table 41. Global Micafungin Sodium for Injection Sales Value Share by Application (2027-2032) Table 42. Global Micafungin Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Micafungin Sodium for Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Micafungin Sodium for Injection Sales Market Share by Region (2021-2026) Table 45. Global Micafungin Sodium for Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Micafungin Sodium for Injection Sales Market Share by Region (2027-2032) Table 47. Global Micafungin Sodium for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Micafungin Sodium for Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Micafungin Sodium for Injection Sales Value Share by Region (2021-2026) Table 50. Global Micafungin Sodium for Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Micafungin Sodium for Injection Sales Value Share by Region (2027-2032) Table 52. Global Micafungin Sodium for Injection Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Micafungin Sodium for Injection Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Micafungin Sodium for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Micafungin Sodium for Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Micafungin Sodium for Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Micafungin Sodium for Injection Sales Market Share by Country (2021-2026) Table 58. Global Micafungin Sodium for Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Micafungin Sodium for Injection Sales Market Share by Country (2027-2032) Table 60. Global Micafungin Sodium for Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Micafungin Sodium for Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Micafungin Sodium for Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Micafungin Sodium for Injection Sales Value Market Share by Country (2027-2032) Table 64. Astellas Company Information Table 65. Astellas Business Overview Table 66. Astellas Micafungin Sodium for Injection Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Astellas Micafungin Sodium for Injection Product Portfolio Table 68. Astellas Recent Development Table 69. Key Raw Materials Table 70. Raw Materials Key Suppliers Table 71. Micafungin Sodium for Injection Distributors List Table 72. Micafungin Sodium for Injection Customers List Table 73. Research Programs/Design for This Report Table 74. Authors List of This Report Table 75. Secondary Sources Table 76. Primary Sources List of Figures Figure 1. Micafungin Sodium for Injection Product Image Figure 2. Global Micafungin Sodium for Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Micafungin Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Micafungin Sodium for Injection Sales (2021-2032) & (K Units) Figure 5. Global Micafungin Sodium for Injection Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Micafungin Sodium for Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50 mg Single-use Vial Image Figure 10. 100 mg Single-use Vial Image Figure 11. Global Micafungin Sodium for Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Micafungin Sodium for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Micafungin Sodium for Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Micafungin Sodium for Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Micafungin Sodium for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Micafungin Sodium for Injection Sales Value Share by Type (2021-2032) Figure 17. Candidemia Image Figure 18. Respiratory Mycosis Image Figure 19. Gastrointestinal Mycosis Image Figure 20. Global Micafungin Sodium for Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Micafungin Sodium for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Micafungin Sodium for Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Micafungin Sodium for Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Micafungin Sodium for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Micafungin Sodium for Injection Sales Value Share by Application (2021-2032) Figure 26. Global Micafungin Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Micafungin Sodium for Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Micafungin Sodium for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Micafungin Sodium for Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Micafungin Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Micafungin Sodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Micafungin Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Micafungin Sodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Micafungin Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Micafungin Sodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Micafungin Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Micafungin Sodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Micafungin Sodium for Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Micafungin Sodium for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Micafungin Sodium for Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Micafungin Sodium for Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg Single-use Vial
  • 100 mg Single-use Vial
Applications
  • Candidemia
  • Respiratory Mycosis
  • Gastrointestinal Mycosis
Companies covered
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Micafungin Sodium for Injection Sales Value (2021-2032)
  4. 1.2.2 Global Micafungin Sodium for Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Micafungin Sodium for Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Micafungin Sodium for Injection Market Dynamics
  1. 2.1 Micafungin Sodium for Injection Industry Trends
  2. 2.2 Micafungin Sodium for Injection Industry Drivers
  3. 2.3 Micafungin Sodium for Injection Industry Opportunities and Challenges
  4. 2.4 Micafungin Sodium for Injection Industry Restraints
3 Micafungin Sodium for Injection Market by Company
  1. 3.1 Global Micafungin Sodium for Injection Company Revenue Ranking in 2025
  2. 3.2 Global Micafungin Sodium for Injection Revenue by Company (2021-2026)
  3. 3.3 Global Micafungin Sodium for Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Micafungin Sodium for Injection Average Price by Company (2021-2026)
  5. 3.5 Global Micafungin Sodium for Injection Company Ranking (2024-2026)
  6. 3.6 Global Micafungin Sodium for Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Micafungin Sodium for Injection Company Product Type and Application
  8. 3.8 Global Micafungin Sodium for Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Micafungin Sodium for Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Micafungin Sodium for Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Micafungin Sodium for Injection Market by Type
  1. 4.1 Micafungin Sodium for Injection Type Introduction
  2. 4.1.1 50 mg Single-use Vial
  3. 4.1.2 100 mg Single-use Vial
  4. 4.2 Global Micafungin Sodium for Injection Sales Volume by Type
  5. 4.2.1 Global Micafungin Sodium for Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Micafungin Sodium for Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Micafungin Sodium for Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Micafungin Sodium for Injection Sales Value by Type
  9. 4.3.1 Global Micafungin Sodium for Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Micafungin Sodium for Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Micafungin Sodium for Injection Sales Value Share by Type (2021-2032)
5 Micafungin Sodium for Injection Market by Application
  1. 5.1 Micafungin Sodium for Injection Application Introduction
  2. 5.1.1 Candidemia
  3. 5.1.2 Respiratory Mycosis
  4. 5.1.3 Gastrointestinal Mycosis
  5. 5.2 Global Micafungin Sodium for Injection Sales Volume by Application
  6. 5.2.1 Global Micafungin Sodium for Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Micafungin Sodium for Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Micafungin Sodium for Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Micafungin Sodium for Injection Sales Value by Application
  10. 5.3.1 Global Micafungin Sodium for Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Micafungin Sodium for Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Micafungin Sodium for Injection Sales Value Share by Application (2021-2032)
6 Micafungin Sodium for Injection Regional Sales and Value Analysis
  1. 6.1 Global Micafungin Sodium for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Micafungin Sodium for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Micafungin Sodium for Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Micafungin Sodium for Injection Sales by Region (2027-2032)
  5. 6.3 Global Micafungin Sodium for Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Micafungin Sodium for Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Micafungin Sodium for Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Micafungin Sodium for Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Micafungin Sodium for Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Micafungin Sodium for Injection Sales Value (2021-2032)
  12. 6.6.2 North America Micafungin Sodium for Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Micafungin Sodium for Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Micafungin Sodium for Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Micafungin Sodium for Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Micafungin Sodium for Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Micafungin Sodium for Injection Sales Value (2021-2032)
  21. 6.9.2 South America Micafungin Sodium for Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Micafungin Sodium for Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Micafungin Sodium for Injection Sales Value Share by Country, 2025 VS 2032
7 Micafungin Sodium for Injection Country-level Sales and Value Analysis
  1. 7.1 Global Micafungin Sodium for Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Micafungin Sodium for Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Micafungin Sodium for Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Micafungin Sodium for Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Micafungin Sodium for Injection Sales by Country (2027-2032)
  6. 7.4 Global Micafungin Sodium for Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Micafungin Sodium for Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Micafungin Sodium for Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Micafungin Sodium for Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Micafungin Sodium for Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Micafungin Sodium for Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Astellas
  2. 8.1.1 Astellas Company Information
  3. 8.1.2 Astellas Business Overview
  4. 8.1.3 Astellas Micafungin Sodium for Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Astellas Micafungin Sodium for Injection Product Portfolio
  6. 8.1.5 Astellas Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Micafungin Sodium for Injection Value Chain Analysis
  2. 9.1.1 Micafungin Sodium for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Micafungin Sodium for Injection Sales Mode & Process
  6. 9.2 Micafungin Sodium for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Micafungin Sodium for Injection Distributors
  9. 9.2.3 Micafungin Sodium for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst